retatrutide phase 2 trial results weight loss vs Tirzepatide: Which Peptide Is More Effective for Fat Loss? Retatrutide Weight Loss Treatment Explained

Quick Answer: Leg pain is not a recognised adverse reaction in the UK Summary of Product Characteristics for Wegovy, though some patients report musculoskeletal discomfort potentially related to rapid weight loss, electrolyte imbalances, or increased physical activity rather than direct drug effects

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-comparator-controlled, parallel-group, phase 2 trial

What to do: Use the group number when submitting claims, especially for employer-sponsored plans, to ensure the correct billing rates and coverage details are applied

However, the warnings came too late for some people, leading them to file an Ozempic lawsuit or a Mounjaro lawsuit against drugmakers Novo Nordisk and Eli Lilly